Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594022 · ClinicalTrials.gov registry record · NA
Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT00594022: Completed NA study, sponsored by Philips Respironics.
NCT00594022 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00594022, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a small electrical current to the vestibular nerve (balance organ) will decrease the time it take for participants to fall asleep.
Primary Outcome
Latency to Persistent Sleep is how long does it take for a person to fall asleep and stay asleep. This is measured in minutes. This is different from sleep onset latency as participants fall asleep, but may wake back up.
Interventions
- DEVICE Electric stimulation of the Vestibular Nerve - "VirtuSom"
- DEVICE Electric stim of the Vestibular Nerve - "VirtuSom" - SHAM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00594022 record still lists
NCT00594022 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Electric stimulation of the Vestibular Nerve - "VirtuSom" is the first listed.
NCT00594022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00594022 about?
NCT00594022 is a clinical study titled "Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness". The purpose of this study is to determine whether a small electrical current to the vestibular nerve (balance organ) will decrease the time it take for participants to fall asleep.
What is the current status of trial NCT00594022?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2007-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00594022?
The interventions under investigation include: Electric stimulation of the Vestibular Nerve - "VirtuSom" (DEVICE), Electric stim of the Vestibular Nerve - "VirtuSom" - SHAM (DEVICE).
Who is sponsoring clinical trial NCT00594022?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00594022's enrollment target sits among peer trials
349 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia